CYP Price Target post MSB FDA approval., page-350

I assume you mean, to include 'to-date' or something similar. Because you don't have a crystal ball (nor do I) and Mesoblast has nominated an intent to do so (yeah, refer to crystal ball comments, previous).

The reason is that they haven't needed to. They were and are right.

I'm critical of Mesoblast on a lot on different things but not on this specific item. A lot has happened but Mesoblast conducted the P3 for GVHD in concert with the FDA. The design of the P3 was given the nod by the FDA before commencement. I am very confident of this and it is the base of what you are eluding here and how you want to make yourself feel good about Cynata.

In a similar vein/vain/whatever spelling, I could say something like: "why does Cynata refuse to do a P3 in aGVHD?". I don't want you to answer, I want you to understand my point - you are making assumptions that they (Mesoblast) don't want to do it because......insert an unproven Cynata narrative here......do you get the point? (Answer that yes or no.....or not?).

Here's another question: Did the FDA waste American taxpayers funds by running a FDA trial that they were never intending could ever be given approval? I don't want you to answer that either - I want you to understand the question - in relation to your question I am answering. The answer is no, BTW.

I am not an 'informed' poster, by my own definition, but, I think that one of the main motives and drivers of Cynata investors is to 'beat Mesoblast'. I don't think that is healthy or smart in any way. Most particularly when it comes from the BoDs. I'm a raving lunatic - always remember that!